Expression changes in arrestin β 1 and genetic variation in catechol-O-methyltransferase are biomarkers for the response to morphine treatment in cancer patients

Author：                                  

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.27, Iss.5, 2012-01, pp. : 1393-1399

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Significance of catechol-O-methyltransferase gene polymorphism in myofacial pain syndrome

By Erdal M. Emin   Herken Hasan   Mutlu M. Necip   Bayazit Yildirim A.  

The Pain Clinic, Vol. 15, Iss. 3, 2003-09 ,pp. : 309-313

Maney Publishing

Access to resources Recommend Favorite

Catechol- O -methyltransferase Val158Met polymorphism in breast cancer risk

By Xi Bo  

Breast Cancer Research and Treatment, Vol. 126, Iss. 3, 2011-04 ,pp. : 839-841

Springer Publishing Company

Access to resources Recommend Favorite

Catechol-O-methyltransferase Val158Met polymorphism and breast cancer risk in Asian population

By Li Kai   Li Wusheng   Zou Huawei  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2343-2350

Springer Publishing Company

Access to resources Recommend Favorite

Combined expression of aldehyde dehydrogenase 1A1 and β-catenin is associated with lymph node metastasis and poor survival in breast cancer patients following cyclophosphamide treatment

By                    

Oncology Reports, Vol. 34, Iss. 6, 2015-01 ,pp. : 3163-3173

Spandidos Publications

Access to resources Recommend Favorite

Useful genetic variation databases for oncologists investigating the genetic basis of variable treatment response and survival in cancer

By Savas Sevtap  

Acta Oncologica, Vol. 49, Iss. 8, 2010-11 ,pp. : 1217-1226

Informa Healthcare

Access to resources Recommend Favorite